Beijing Wandong Medical Technology Co.,Ltd. (SHA:600055)
18.44
+0.04 (0.22%)
May 23, 2025, 2:45 PM CST
SHA:600055 Revenue
Beijing Wandong Medical Technology had revenue of 373.28M CNY in the quarter ending March 31, 2025, with 21.00% growth. This brings the company's revenue in the last twelve months to 1.59B, up 23.18% year-over-year. In the year 2024, Beijing Wandong Medical Technology had annual revenue of 1.52B with 23.26% growth.
Revenue (ttm)
1.59B
Revenue Growth
+23.18%
P/S Ratio
8.14
Revenue / Employee
1.33M
Employees
1,059
Market Cap
12.94B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.52B | 287.68M | 23.26% |
Dec 31, 2023 | 1.24B | 115.47M | 10.30% |
Dec 31, 2022 | 1.12B | -34.97M | -3.02% |
Dec 31, 2021 | 1.16B | 24.27M | 2.14% |
Dec 31, 2020 | 1.13B | 149.53M | 15.22% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |